Venrock Adviser, LLC
NEW YORK, NY · CIK 1615982 · 13F filing filed 2023-11-14
SEC-registered investment adviser since 2014 · limited liability company
- Assets managed$4.5bn
- Staff11 · 11 in investment roles
- Main clients (by assets)Private funds 100%
- Private funds7 (1 hedge) · $4.5bn gross assets
- Form ADV · 2026-04-28SEC adviser record
- Legal entityVENROCK ADVISER, LLC (US)
- Kindhedge funds, private equity
- Others nearbyNew York, NY, Palo Alto, CA
As an employer
- Offices in1 country
- Private fundshedge 1, private equity 6
Where they work
Offices
From Form ADV: the main office and the other offices where it does advisory work (at most the 25 largest), with the people doing investment work at each. “About” is worked out: the firm's investment staff less its other offices. Each city links to the other managers there.
| City | People |
|---|---|
| New York, NY (main office)United States | about 11 |
| Palo Alto, CAUnited States |
Map: places from GeoNames (CC BY 4.0), outlines from Natural Earth.
$949.9m
reported value
+51.9% vs Q2 2023
37positions
62.2%in top 10
10 new
7 added
3 reduced
3 sold out
vs Q2 2023
Holdings, Q3 2023
The small lines show how much was held over the last 4 quarters (adjusted for stock splits).
| Security | Value | Change |
|---|---|---|
| APOGEE THERAPEUTICS INC COM | $180.9m19.04% | New |
| RAYZEBIO INC COM | $89.2m9.39% | New |
| VIRIDIAN THERAPEUTICS INC VRDN | $47.3m4.98% | Unchanged |
| COGENT BIOSCIENCES INC COGT | $45.7m4.81% | Added +35 |
| TAYSHA GENE THERAPIES INC TSHA | $45.6m4.80% | New |
| MERUS N V MRUS | $40.7m4.28% | Unchanged |
| ENLIVEN THERAPEUTICS INC ELVN | $40.4m4.25% | Added +724.8k |
| 4D MOLECULAR THERAPEUTICS IN FDMT | $38.2m4.02% | Unchanged |
| PHARVARIS N V PHVS | $32.6m3.43% | Added +237.3k |
| CABALETTA BIO INC CABA | $30.0m3.16% | Added +2 |
| KALVISTA PHARMACEUTICALS INC KALV | $28.1m2.96% | Unchanged |
| GH RESEARCH PLC GHRS | $27.6m2.90% | Reduced -773.0k |
| HILLEVAX INC COM | $27.4m2.88% | New |
| SAVARA INC SVRA | $27.2m2.86% | Added +833.3k |
| RHYTHM PHARMACEUTICALS INC RYTM | $25.0m2.63% | Unchanged |
| AMBRX BIOPHARMA INC SPONSORED ADS | $23.8m2.51% | Reduced -415.0k |
| TRAVERE THERAPEUTICS INC TVTX | $23.5m2.47% | New |
| DYNE THERAPEUTICS INC DYN | $19.5m2.05% | Unchanged |
| CELCUITY INC CELC | $19.2m2.03% | Unchanged |
| TERNS PHARMACEUTICALS INC COM | $15.6m1.64% | Added +119.4k |
| MERSANA THERAPEUTICS INC COM | $14.4m1.51% | New |
| APPLIED THERAPEUTICS INC APLT | $14.1m1.48% | Unchanged |
| ORIC PHARMACEUTICALS INC ORIC | $13.0m1.36% | Unchanged |
| DIANTHUS THERAPEUTICS INC DNTH | $12.7m1.33% | New |
| ADVERUM BIOTECHNOLOGIES INC COM | $9.9m1.04% | Added +2.7m |
| PRAXIS PRECISION MEDICINES I COM | $9.1m0.95% | Unchanged |
| ACELYRIN INC COM | $8.8m0.93% | New |
| TREVI THERAPEUTICS INC TRVI | $7.5m0.79% | Unchanged |
| ACLARIS THERAPEUTICS INC ACRS | $7.1m0.75% | Unchanged |
| MILESTONE PHARMACEUTICALS IN MIST | $6.8m0.72% | Unchanged |
| PLIANT THERAPEUTICS INC PLRX | $5.0m0.53% | Unchanged |
| SAGIMET BIOSCIENCES INC SGMT | $4.5m0.48% | New |
| AEGLEA BIOTHERAPEUTICS INC AGLE | $3.6m0.38% | Reduced -6.0m |
| LYRA THERAPEUTICS INC LYRA | $3.6m0.38% | Unchanged |
| OLEMA PHARMACEUTICALS INC OLMA | $951.5k0.10% | New |
| RALLYBIO CORP COM | $905.0k0.10% | Unchanged |
| AFFIMED N V COM | $682.7k0.07% | Unchanged |
Sold out since Q2 2023
| Security | Value then |
|---|---|
| THESEUS PHARMACEUTICALS INC | $7.2m770.0k shares |
| BLACK DIAMOND THERAPEUTICS I BDTX | $1.8m353.6k shares |
| AVALO THERAPEUTICS INC | $444.0k1.2m shares |